These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36240909)

  • 1. Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001-2017.
    Mix JM; Gopalani SV; Simko S; Saraiya M
    Prev Med; 2022 Nov; 164():107302. PubMed ID: 36240909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018.
    Berenson AB; Chang M; Hawk ET; Ramondetta LM; Hoang T
    Cancer Prev Res (Phila); 2022 Nov; 15(11):777-784. PubMed ID: 35969832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of in situ and invasive vulvar cancer in the US, 1998-2003.
    Saraiya M; Watson M; Wu X; King JB; Chen VW; Smith JS; Giuliano AR
    Cancer; 2008 Nov; 113(10 Suppl):2865-72. PubMed ID: 18980209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
    Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
    JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year relative survival for human papillomavirus-associated cancer sites.
    Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
    Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
    J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of HPV-associated female genital cancers in the United States, 1999-2004.
    Watson M; Saraiya M; Wu X
    J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma.
    de Koning MN; Quint WG; Pirog EC
    Mod Pathol; 2008 Mar; 21(3):334-44. PubMed ID: 18192968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma.
    Eva LJ; Sadler L; Fong KL; Sahota S; Jones RW; Bigby SM
    Gynecol Oncol; 2020 May; 157(2):450-455. PubMed ID: 32037194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic and temporal variations in the incidence of vulvar and vaginal cancers.
    Bray F; Laversanne M; Weiderpass E; Arbyn M
    Int J Cancer; 2020 Nov; 147(10):2764-2771. PubMed ID: 32410226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
    Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
    Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of vulvar squamous cell carcinoma in Japanese women.
    Osakabe M; Hayashi M; Katayama Y; Emura I; Nemoto K; Umezu H; Saitoh K; Motoyama T
    Pathol Int; 2007 Jun; 57(6):322-7. PubMed ID: 17539962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV prevalence in vulvar cancer in Austria.
    Pils S; Gensthaler L; Alemany L; Horvat R; de Sanjosé S; Joura EA
    Wien Klin Wochenschr; 2017 Nov; 129(21-22):805-809. PubMed ID: 28884278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of human papillomavirus infection in polish patients with vulvar squamous cell carcinoma.
    Kowalewska M; Szkoda MT; Radziszewski J; Ptaszynski K; Bidzinski M; Siedlecki JA
    Int J Gynecol Cancer; 2010 Apr; 20(3):434-7. PubMed ID: 20375810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases.
    Al-Ghamdi A; Freedman D; Miller D; Poh C; Rosin M; Zhang L; Gilks CB
    Gynecol Oncol; 2002 Jan; 84(1):94-101. PubMed ID: 11748983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
    Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
    Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends in prevalence of p16 positivity and combined HPV/p16 positivity in a large cohort of Danish vulvar cancer patients.
    Rasmussen CL; Thomsen LT; Baandrup L; Franzmann MB; Kjaer AK; Larsen LG; Madsen EM; Salinas NMV; Schledermann D; Winberg BH; Ørnskov D; Waldstrøm M; Kjaer SK
    Int J Cancer; 2023 Jun; 152(11):2424-2432. PubMed ID: 36694992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trends in human papillomavirus prevalence and genotype distribution in vulvar carcinoma in Norway.
    Meltzer-Gunnes CJ; Lie AK; Jonassen CGM; Rangberg A; Nystrand CF; Småstuen MC; Vistad I
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):153-164. PubMed ID: 37904590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
    Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
    Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in HPV prevalence in Danish women with vulvar cancer during 28 years - A nationwide study of >1300 cancer cases.
    Rasmussen CL; Thomsen LT; Baandrup L; Franzmann MB; Larsen LG; Madsen EM; Salinas NV; Schledermann D; Winberg BH; Ørnskov D; Waldstrøm M; Kjaer SK
    Gynecol Oncol; 2022 Sep; 166(3):589-595. PubMed ID: 35750502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.